StockData
Reviva Pharmaceuticals Holdings, Inc. logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock

RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 2/30
$0.45−0.02 (-4.36%)

Close on Oct 19, 2026Market cap $5.94MP/E –Yield –

Reviva Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Reviva Pharmaceuticals's market cap was $5.90M on Oct 19, 2026, against $41.83M a year earlier. Over the last 5 years it ranged from $4.29M to $143.66M, with a median of $41.83M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$5.90M-78.6%
2025Dec 31, 2025$27.57M-55.6%
2024Dec 31, 2024$62.08M-43.1%
2023Dec 29, 2023$109.08M+22.4%
2022Dec 30, 2022$89.11M+124.5%
2021Dec 31, 2021$39.69M+57.7%
2020Dec 31, 2020$25.17M–

More Reviva Pharmaceuticals figures

See a number that looks wrong?